CA
SILK

Crewe Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Crewe Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-61
Closed -$2.39K – 1027
2023
Q1 		$2.39K Hold
61
– – ﹤0.01% 707
2022
Q4 		$3.22K Hold
61
– – ﹤0.01% 759
2022
Q3 		$3K Hold
61
– – ﹤0.01% 1006
2022
Q2 		$2K Buy
+61
New +$2.22K ﹤0.01% 1030

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Crewe Advisors's SILK Position: Q2 2023 in Review

Crewe Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 61 shares — an estimated $2.39K sold.

Crewe Advisors first reported a position in SILK in Q2 2022 and held it in 4 quarters. The position peaked at $3.22K in Q4 2022. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

  • Crewe Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Crewe Advisors sold 61 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $2.39K.
  • Crewe Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Crewe Advisors's Silk Road Medical, Inc. Common Stock position peaked at $3.22K in Q4 2022.
  • 173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Crewe Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.